Obesity, voracity, and short stature:: the impact of glutamate on the regulation of appetite

被引:80
作者
Hermanussen, M
García, AP
Sunder, M
Voigt, M
Salazar, V
Tresguerres, JAF
机构
[1] Univ Complutense, Dept Physiol, Sch Med, Madrid, Spain
[2] Univ Munich, Volkswirtschaftliches Inst, Munich, Germany
[3] Univ Greifswald, Zentrum Kinder & Jugendmed, Dept Neonatol & Paediat Intens Care, Greifswald, Germany
关键词
obesity; voracity; short stature; glutamate; arcuate nucleus;
D O I
10.1038/sj.ejcn.1602263
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background: World-wide obesity has risen to alarming levels. We present experimental support for a new and very challenging hypothesis linking obesity, voracity, and growth hormone (GH) deficiency, to the consumption of elevated amounts of the amino-acid glutamate (GLU). Supraphysiological doses of GLU are toxic for neuronal cells. Methods: Human data were obtained from 807 592 German conscripts born between 1974 and 1978, and from 1 432 368 women of the German birth statistics (deutsche Perinatalerhebung) 1995 - 1997. The effects of orally administered monosodium glutamate (MSG) were investigated in 30 pregnant Wistar rats and their offspring. Pregnant animals either received no extra MSG, or 2.5 g MSG, or 5 g MSG per day, up to the end of the weaning period. In all, 2.5 g, respectively 5 g, MSG accounted for some 10%, respectively 20%, of dry weight of the average daily food ration. After weaning, MSG feeding was continued in the offspring. Findings: Morbid obesity associates with short stature. Average stature of conscripts progressively declines when body mass index increases above 38 kg/m(2). Also morbidly obese young women are shorter than average though to a lesser extent than conscripts. Oral administration of MSG to pregnant rats affects birth weight of the offspring. Maternal feeding with 5 g MSG per day results in severe birth weight reduction (P<0.01). Weight increments remain subnormal when MSG feeding to the mothers is maintained during weaning (P<0.01). GH serum levels are affected in animals that received MSG during prenatal life via maternal feeding. Animals that are kept on high MSG diet ( 5 g MSG per day) continue to show serum GH levels that are as low or even lower than those of MSG injected animals (P<0.05), both at day 30 and at day 90 of life. Animals that were kept on medium MSG diet ( 2.5 g MSG per day) showed low serum GH levels at day 30 of life (P<0.01), but seemed to partially recover before day 90. Almost identical results were observed in IGF-1 serum levels. Oral MSG resulted in dose dependent voracity. The animals fed 5 g MSG per day increased water uptake by threefold (P<0.01), and food uptake by almost two-fold (P<0.01). The influence of MSG is in general more marked in males than in females. Interpretation: GLU is a widely used nutritional substance that potentially exhibits significant neuronal toxicity. Voracity, and impaired GH secretion are the two major characteristics of parenterally administered GLU-induced neuronal damage. GLU maintains its toxicity in animals even when administered orally. Males appear to be more sensitive than females. The present study for the first time demonstrates, that a widely used nutritional monosubstance - the flavouring agent MSG - at concentrations that only slightly surpass those found in everyday human food, exhibits significant potential for damaging the hypothalamic regulation of appetite, and thereby determines the propensity of world-wide obesity. We suggest to reconsider the recommended daily allowances of amino acids and nutritional protein, and to abstain from the popular protein-rich diets, and particularly from adding the flavouring agents MSG.
引用
收藏
页码:25 / 31
页数:7
相关论文
共 39 条
  • [1] Azcoitia I, 1999, J NEUROSCI RES, V58, P815, DOI 10.1002/(SICI)1097-4547(19991215)58:6<815::AID-JNR8>3.0.CO
  • [2] 2-R
  • [3] Changes in NMDA-receptor gene expression are associated with neurotoxicity induced neonatally by glutamate in the rat brain
    Beas-Zárate, C
    Rivera-Huizar, SV
    Martinez-Contreras, A
    Feria-Velasco, A
    Armendariz-Borunda, J
    [J]. NEUROCHEMISTRY INTERNATIONAL, 2001, 39 (01) : 1 - 10
  • [4] BLOCH B, 1984, NATURE, V307, P272, DOI 10.1038/307272a0
  • [5] A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction
    Clément, K
    Vaisse, C
    Lahlou, N
    Cabrol, S
    Pelloux, V
    Cassuto, D
    Gourmelen, M
    Dina, C
    Chambaz, J
    Lacorte, JM
    Basdevant, A
    Bougneres, P
    Lebouc, Y
    Froguel, P
    Guy-Grand, B
    [J]. NATURE, 1998, 392 (6674) : 398 - 401
  • [6] The protective role of endogenous estrogens in carrageenan-induced lung injury in the rat
    Cuzzocrea, S
    Mazzon, E
    Sautebin, L
    Serraino, I
    Dugo, L
    Calabró, G
    Caputi, AP
    Maggi, A
    [J]. MOLECULAR MEDICINE, 2001, 7 (07) : 478 - 487
  • [7] Hypothalamic pathways underlying the endocrine, autonomic, and behavioral effects of leptin
    Elmquist, JK
    [J]. INTERNATIONAL JOURNAL OF OBESITY, 2001, 25 (Suppl 5) : S78 - S82
  • [8] Role of melanocortinergic neurons in feeding and the agouti obesity syndrome
    Fan, W
    Boston, BA
    Kesterson, RA
    Hruby, VJ
    Cone, RD
    [J]. NATURE, 1997, 385 (6612) : 165 - 168
  • [9] Dominant and recessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency
    Farooqi, IS
    Yeo, GSH
    Keogh, JM
    Aminian, S
    Jebb, SA
    Butler, G
    Cheetham, T
    O'Rahilly, S
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2000, 106 (02) : 271 - 279
  • [10] Hermanussen M, 1996, GROWTH REGULAT, V6, P230